Stock Ratios
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
profit margin TTM
-1013.0%
operating margin TTM
-960.49%
revenue TTM
3.16 Million
revenue per share TTM
0.44$
valuation ratios | |
|---|---|
| pe ratio | -0.67 |
| peg ratio | -0.08 |
| price to book ratio | 4.78 |
| price to sales ratio | 7.68 |
| enterprise value multiple | -0.88 |
| price fair value | 4.78 |
profitability ratios | |
|---|---|
| gross profit margin | 7.89% |
| operating profit margin | -960.49% |
| pretax profit margin | -954.17% |
| net profit margin | -1013.0% |
| return on assets | -186.31% |
| return on equity | -303.92% |
| return on capital employed | -359.8% |
liquidity ratio | |
|---|---|
| current ratio | 1.20 |
| quick ratio | 1.06 |
| cash ratio | 0.81 |
efficiency ratio | |
|---|---|
| days of inventory outstanding | 144.92 |
| operating cycle | 267.68 |
| days of payables outstanding | 328.11 |
| cash conversion cycle | -60.42 |
| receivables turnover | 2.97 |
| payables turnover | 1.11 |
| inventory turnover | 2.52 |
debt and solvency ratios | |
|---|---|
| debt ratio | 0.32 |
| debt equity ratio | 1.22 |
| long term debt to capitalization | 0.00 |
| total debt to capitalization | 0.55 |
| interest coverage | 0.00 |
| cash flow to debt ratio | -5.00 |
cash flow ratios | |
|---|---|
| free cash flow per share | -1.88 |
| cash per share | 0.48 |
| operating cash flow per share | -1.88 |
| free cash flow operating cash flow ratio | 1.00 |
| cash flow coverage ratios | -5.00 |
| short term coverage ratios | -61.27 |
| capital expenditure coverage ratio | -5,415.78 |
Frequently Asked Questions
When was the last time Predictive Oncology Inc. (NASDAQ:POAI) reported earnings?
Predictive Oncology Inc. (POAI) published its most recent earnings results on 12-11-2024.
What is Predictive Oncology Inc.'s current ROE?
An investor's main concern is the profitability ratios of a company so that they are able to understand how it performs financially. Investors are interested in finding out how effectively a business is using their cash to produce earnings, which is why return on equity (ROE) ratio is important. Predictive Oncology Inc. (NASDAQ:POAI)'s trailing twelve months ROE is -303.92%.
What are ROA telling us?
The Return on Assets (ROA) ratio measures how profitable a company is relative to its total assets. Predictive Oncology Inc. (POAI) currently has a ROA of -186.31%. Companies that manage their assets effectively will have greater returns, while those that do so poorly would suffer lower returns.
Where did POAI's net profit margin stand at?
POAI reported a profit margin of -1013.0% in the last quarter. A company's profit margin, also known as its revenue ratio or gross profit ratio, reflects the amount of revenue that an organization earns compared to its net income. In general, a higher ratio implies greater profit, and vice versa.
What is POAI's short-term liquidity position?
Apple's current ratio, which measures its ability to pay short-term obligations, was 1.20 in the most recent quarter. The quick ratio stood at 1.06, with a Debt/Eq ratio of 1.22.